Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Cavero

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Medicina Clinica|April 28, 2018
Where are we with haemolytic uremic syndrome?Teresa Cavero, Marina Alonso
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|November 22, 2014
Reply to the comment on “Acute Rejection of Non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin”Teresa Cavero-Escribano, Enrique Morales-Ruiz
Kidney International|October 26, 2019
The authors replyTeresa Cavero, Santiago Rodríguez de Córdoba, Manuel Praga
Nephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.
Nefrologia|May 3, 2018
Eculizumab as a treatment for atypical hemolytic syndrome secondary to carfilzomibCandela Moliz, Eduardo Gutiérrez, Teresa Cavero, et al.
Kidney International Reports|June 20, 2024
Kidney Transplantation Outcomes of Patients With Chronic Hypotension in DialysisPilar Auñón, Teresa Cavero, Ana García, et al.
Nephron|September 20, 2020
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage EraAna Isabel Avila Bernabeu, Teresa Cavero Escribano, Mercedes Cao Vilarino
Nefrologia|October 17, 2019
Renal damage secondary to check-point inhibitorsCandela Moliz, Teresa Cavero, Enrique Morales, et al.
Clinical Kidney Journal|February 10, 2021
Long-term validation of the renal risk score for vasculitis in a Southern European populationJavier Villacorta, Francisco Diaz-Crespo, Carmen Guerrero, et al.
Clinical Transplantation|August 29, 2024
Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung TransplantationHernando Trujillo, Ana Huerta, Rodrigo Alonso, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Medicina Clinica|April 28, 2018
Where are we with haemolytic uremic syndrome?Teresa Cavero, Marina Alonso
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|November 22, 2014
Reply to the comment on “Acute Rejection of Non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin”Teresa Cavero-Escribano, Enrique Morales-Ruiz
Kidney International|October 26, 2019
The authors replyTeresa Cavero, Santiago Rodríguez de Córdoba, Manuel Praga
Nephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.
Nefrologia|May 3, 2018
Eculizumab as a treatment for atypical hemolytic syndrome secondary to carfilzomibCandela Moliz, Eduardo Gutiérrez, Teresa Cavero, et al.
Kidney International Reports|June 20, 2024
Kidney Transplantation Outcomes of Patients With Chronic Hypotension in DialysisPilar Auñón, Teresa Cavero, Ana García, et al.
Nephron|September 20, 2020
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage EraAna Isabel Avila Bernabeu, Teresa Cavero Escribano, Mercedes Cao Vilarino
Nefrologia|October 17, 2019
Renal damage secondary to check-point inhibitorsCandela Moliz, Teresa Cavero, Enrique Morales, et al.
Clinical Kidney Journal|February 10, 2021
Long-term validation of the renal risk score for vasculitis in a Southern European populationJavier Villacorta, Francisco Diaz-Crespo, Carmen Guerrero, et al.
Clinical Transplantation|August 29, 2024
Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung TransplantationHernando Trujillo, Ana Huerta, Rodrigo Alonso, et al.
Pageof 5